Acadia Healthcare Enters Material Agreement, New Financial Obligation

TL;DR

**Acadia Healthcare just entered a material agreement and took on a new financial obligation; details pending.**

AI Summary

Acadia Healthcare Company, Inc. filed an 8-K on January 19, 2024, reporting an event that occurred on January 18, 2024. This filing indicates an "Entry into a Material Definitive Agreement" and the "Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement." While the specific details of the agreement and obligation are not disclosed in this summary, the filing signals a significant corporate action that could impact the company's financial structure or future operations. Investors should monitor for further disclosures to understand the nature and potential financial implications of this new agreement or obligation.

Why It Matters

This filing signals a potentially significant change in Acadia Healthcare's financial or operational landscape, which could affect its future earnings, debt levels, or strategic direction. Investors need to understand the specifics of this agreement to assess its impact on the company's valuation and risk profile.

Risk Assessment

Risk Level: medium — The filing indicates a material agreement and new financial obligation without providing specifics, creating uncertainty about potential positive or negative impacts.

Analyst Insight

Investors should await further disclosures from Acadia Healthcare Company, Inc. to understand the specific terms and financial implications of the material definitive agreement and new financial obligation before making any investment decisions.

Key Players & Entities

• Acadia Healthcare Company, Inc. (company) — the registrant filing the 8-K
• January 18, 2024 (date) — date of the earliest event reported
• January 19, 2024 (date) — date the 8-K was filed
• Delaware (company) — state of incorporation for Acadia Healthcare Company, Inc.
• 6100 Tower Circle, Suite 1000, Franklin, Tennessee, 37067 (company) — business address of Acadia Healthcare Company, Inc.
• 001-35331 (company) — Commission File Number for Acadia Healthcare Company, Inc.
• ACHC (company) — trading symbol for Acadia Healthcare Company, Inc. on NASDAQ Global Select Market

FAQ

Key Financial Figures

• $0.01 — nge on which registered Common stock, $0.01 par value per share ACHC NASDAQ Glo
• $600 million — xisting Credit Agreement provides for a $600 million senior secured revolving credit facilit
• $425 million — lity (the " Revolving Facility ") and a $425 million senior secured term loan facility (the
• $350 million — ans in an aggregate principal amount of $350 million (the " Incremental Term Loans "). Such

Filing Documents

• d658459d8k.htm (8-K) — 30KB
• d658459dex101.htm (EX-10.1) — 1120KB
• 0001193125-24-011225.txt ( ) — 1516KB
• achc-20240118.xsd (EX-101.SCH) — 3KB
• achc-20240118_lab.xml (EX-101.LAB) — 18KB
• achc-20240118_pre.xml (EX-101.PRE) — 11KB
• d658459d8k_htm.xml (XML) — 3KB

01

Item 1.01. Entry into a Material Definitive Agreement On January 18, 2024, Acadia Healthcare Company, Inc. (the " Company ") and the Guarantors (as defined below) entered into that certain Amendment No. 2 to Credit Agreement (the " Amendment ") with Bank of America, N.A., as administrative agent (the " Administrative Agent ") and certain lenders party thereto, which amends the Credit Agreement, dated as of March 17, 2021, among the Company, the Administrative Agent and the lenders from time to time party thereto (as previously amended, the " Existing Credit Agreement ," and the Existing Credit Agreement as amended by the Amendment, the " Amended Credit Agreement "). The Existing Credit Agreement provides for a $600 million senior secured revolving credit facility (the " Revolving Facility ") and a $425 million senior secured term loan facility (the " Existing Term Loan Facility "), each maturing on March 17, 2026 unless extended in accordance with the terms of the Existing Credit Agreement. The Amendment provides for the incurrence of additional senior secured term loans in an aggregate principal amount of $350 million (the " Incremental Term Loans "). Such Incremental Term Loans are structured as an increase of the Existing Term Loan Facility. The maturity date, the leverage-based pricing grid, amortization, mandatory prepayment events and other terms applicable to the Incremental Term Loans are substantially identical to those applicable to the Existing Term Loan Facility that were in effect prior to the Amendment. After giving effect to the Amendment and the Incremental Term Loans, borrowings under the Amended Credit Agreement bear interest at a floating rate equal to, at the option of the Company, (i) adjusted SOFR plus 1.50% or (ii) an alternative base rate plus 0.500% (in each case, subject to future adjustment based on changes to the Company's consolidated total net leverage ratio). The proceeds of the Incremental Term Loans are available to the Compan

03

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant The information set forth in Item 1.01 above is incorporated by reference into this Item 2.03.

Financial Statements and Exhibits

Financial Statements and Exhibits (d) Exhibits Exhibit No. Description of Exhibit 10.1 Amendment No. 2 to Credit Agreement, dated as of January 18, 2024, among Acadia Healthcare Company, Inc., certain subsidiaries of Acadia Healthcare Company, Inc., as guarantors, the lenders party thereto, and Bank of America, N.A., as Administrative Agent. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Acadia Healthcare Company, Inc. By: /s/Brian P. Farley Brian P. Farley Executive Vice President and General Counsel Date: January 19, 2024

View Full Filing

View this 8-K filing on SEC EDGAR